US Patent 7265140 Acyloxymethylcarbamate prodrugs of oxazolidinones
Patent 7265140 was granted and assigned to Pfizer on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Allison Laura Choy0
Frederick Earl Boyer0
Ji-Young Kim0
Lisa Marie Thomasco0
Robert C. Gadwood0
Vara Prasad Venkata Nagendra Josyula0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+232 characters)
Article
Patent abstract
The present invention relates to acyloxymethylcarbamate oxazolidinones. The compounds of the present invention have potent activity with excellent oral bioavailability against Gram-positive and Gram-negative bacteria.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07265140 Acyloxymethylcarbamate prodrugs of oxazolidinones US Patent 7265140 Acyloxymethylcarbamate prodrugs of oxazolidinones
Infobox
Patent Number
07265140
Patent Number
7265140
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07265140 Acyloxymethylcarbamate prodrugs of oxazolidinones
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07265140
Date of patent
September 4, 2007
Patent application number
10937187
Date Filed
September 9, 2004
Patent primary examiner
Find more entities like US Patent 7265140 Acyloxymethylcarbamate prodrugs of oxazolidinones
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
